For example, Pailler et al., examined ALK rearrangements in CTCs of NSCLC patients and found four or more ALK-rearranged CTCs per 1 ml of blood, with 100% sensitivity and specificity [17]. This evidence concerns the gene ALK and non-small cell lung carcinoma.